Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review

@article{Nakagomi2013IncorporationOA,
  title={Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review},
  author={Osamu Nakagomi and Miren Iturriza-G{\'o}mara and Toyoko Nakagomi and Nigel A. Cunliffe},
  journal={Expert Opinion on Biological Therapy},
  year={2013},
  volume={13},
  pages={1613 - 1621}
}
Introduction: Rotavirus, the commonest cause of severe acute gastroenteritis in infants and young children worldwide, imposes a large health and economic burden on the British society, accounting for an estimated 14,300 hospitalisations and 133,000 general practitioner consultations each year among children aged < 5 years in England and Wales alone. Following a tender process, an attenuated human rotavirus vaccine, Rotarix (GlaxoSmithKline Biologicals, Belgium), was introduced into the UK… 

Ecological assessment of the direct and indirect effects of routine rotavirus vaccination in Merseyside, UK using data from multiple health systems: a study protocol

The study will demonstrate the impact of rotavirus vaccination on the burden of disease from a complete health system perspective and provide a template for vaccine evaluations using ecological methods in the UK.

What Are The New Vaccines Against Rotavirus ?

Rotavirus vaccine is a very effective option in terms of efficacy, cost and safety against viral diarrhoea caused by Rotavirus and consideration should be given to include this vaccine in EPI programme of developing countries.

Occurrence of severe rotavirus gastroenteritis in children younger than three years of age before and after the introduction of rotavirus vaccine: a prospective observational study in four pediatric clinics in Shibata City, Niigata Prefecture, Japan

The incidence rate of severe rotavirus gastroenteritis (RVGE) was significantly lower in the plateau era than in the pre-vaccine introduction and transitional eras and the number of hospitalizations due to RVGE in subjects who required or did not require intravenous rehydration at the pediatric clinics significantly decreased with the increase in vaccine coverage rates.

An Early Detection of Decline in Rotavirus Cases during the 2013/2014 Season in Japan as Revealed by Time-series Analysis of National Surveillance Data

An application of a time-series analysis on a publicly-available dataset in Japan on the weekly number of laboratory-confirmed rotavirus-positive samples over the last 5 year period suggests that the use of rotav virus vaccine had a positive impact on reducing the burden of rotvirus diarrhoea in Japan.

Increased detection of G3P[9] and G6P[9] rotavirus strains in hospitalized children with acute diarrhea in Bulgaria.

Vaccines against human diarrheal pathogens

Currently available vaccines against diarrheal infectious diseases are Vibrio cholerae, Shigella spp.

Incidence of household transmission of acute gastroenteritis (AGE) in a primary care sentinel network (1992–2017): cross-sectional and retrospective cohort study protocol

This study used the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) primary care sentinel network, comprising data from 1 750 167 registered patients, and conducted a novel analysis using a ’household key', to identify patients within the same household.

A ‘cocoon immunization strategy’ among patients with inflammatory bowel disease

The use of nonmandatory vaccines recommended in family members of patients with IBD is insufficient and further vaccine promotion and education of patients as well as their healthcare providers is required.

References

SHOWING 1-10 OF 48 REFERENCES

Ecological assessment of the direct and indirect effects of routine rotavirus vaccination in Merseyside, UK using data from multiple health systems: a study protocol

The study will demonstrate the impact of rotavirus vaccination on the burden of disease from a complete health system perspective and provide a template for vaccine evaluations using ecological methods in the UK.

Rotavirus vaccines: current prospects and future challenges

Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?

Vaccines for preventing rotavirus diarrhoea: vaccines in use.

Evaluating rotavirus vaccines approved for use (RV1, RV5, and LLR) for preventingRotavirus diarrhoea in children with high-mortality rates found that RV1 probably prevents 40% of severe all-cause diarrhoeA episodes, and RV5probably prevents 40%, based on one large multicentre trial in Latin America and Finland.

Unexpected benefits of rotavirus vaccination in the United States.

  • R. Glass
  • Medicine
    The Journal of infectious diseases
  • 2011
The impact of the introduction of rotavirus vaccines in the United States is document and some surprises are found that could not have been fully anticipated or predicted in advance.

Global impact of rotavirus vaccines

Early clinical trial data from Africa and Asia are promising, and further efforts are needed to optimize the benefits of vaccination in developing countries where vaccines are likely to have their greatest impact.